{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T16:02:25Z","timestamp":1780761745725,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82272100"],"award-info":[{"award-number":["No. 82272100"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82302332"],"award-info":[{"award-number":["No. 82302332"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1245\/s10434-026-19504-5","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T16:22:50Z","timestamp":1776097370000},"page":"6274-6285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combined RAS and SMAD4 Mutations and Microsatellite Instability Predict Outcomes in Colorectal Lung Metastases Treated with Image-Guided Thermal Ablation"],"prefix":"10.1245","volume":"33","author":[{"given":"Tao","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuancheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aibin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyou","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangping","family":"Cun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bufu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwen","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"19504_CR1","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27:1386\u2013422. https:\/\/doi.org\/10.1093\/annonc\/mdw235.","journal-title":"Ann Oncol"},{"key":"19504_CR2","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.athoracsur.2008.12.061","volume":"87","author":"A Pennathur","year":"2009","unstructured":"Pennathur A, Abbas G, Qureshi I, et al. Radiofrequency ablation for the treatment of pulmonary metastases. Ann Thorac Surg. 2009;87:1030\u20139. https:\/\/doi.org\/10.1016\/j.athoracsur.2008.12.061.","journal-title":"Ann Thorac Surg."},{"key":"19504_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/1759-7714.12567","volume":"9","author":"H Qi","year":"2018","unstructured":"Qi H, Fan W. Value of ablation therapy in the treatment of lung metastases. Thorac Cancer. 2018;9:199\u2013207. https:\/\/doi.org\/10.1111\/1759-7714.12567.","journal-title":"Thorac Cancer"},{"key":"19504_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/JS9.0000000000000782","volume":"110","author":"H Fan","year":"2024","unstructured":"Fan H, Xie X, Pang Z, et al. Risk assessment of pneumothorax in colorectal lung metastases treated by percutaneous thermal ablation: a multicenter retrospective cohort study. Int J Surg. 2024;110:261\u20139. https:\/\/doi.org\/10.1097\/JS9.0000000000000782.","journal-title":"Int J Surg"},{"key":"19504_CR5","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1097\/SLA.0000000000002450","volume":"269","author":"YS Chun","year":"2019","unstructured":"Chun YS, Passot G, Yamashita S, et al. Deleterious effect of RAS and evolutionary high-risk TP53 double mutation in colorectal liver metastases. Ann Surg. 2019;269:917\u201323. https:\/\/doi.org\/10.1097\/SLA.0000000000002450.","journal-title":"Ann Surg"},{"key":"19504_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00534-012-0531-9","volume":"20","author":"Y Umeda","year":"2013","unstructured":"Umeda Y, Nagasaka T, Mori Y, et al. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability. J Hepato-Biliary-Pancreat Sci. 2013;20:223\u201333. https:\/\/doi.org\/10.1007\/s00534-012-0531-9.","journal-title":"J Hepato-Biliary-Pancreat Sci"},{"key":"19504_CR7","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ejso.2018.02.247","volume":"44","author":"T Mizuno","year":"2018","unstructured":"Mizuno T, Cloyd JM, Vicente D, et al. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases. EJSO. 2018;44:684\u201392. https:\/\/doi.org\/10.1016\/j.ejso.2018.02.247.","journal-title":"EJSO"},{"key":"19504_CR8","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/bjc.2014.499","volume":"112","author":"S Renaud","year":"2015","unstructured":"Renaud S, Romain B, Falcoz PE, et al. KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer. Br J Cancer. 2015;112:720\u20138. https:\/\/doi.org\/10.1038\/bjc.2014.499.","journal-title":"Br J Cancer"},{"key":"19504_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1021\/acs.jproteome.2c00551","volume":"22","author":"JJ Dijkstra","year":"2023","unstructured":"Dijkstra JJ, Neikes HK, Rezaeifard S, et al. Multiomics of colorectal cancer organoids reveals putative mediators of cancer progression resulting from SMAD4 inactivation. J Proteome Res. 2023;22:138\u201351. https:\/\/doi.org\/10.1021\/acs.jproteome.2c00551.","journal-title":"J Proteome Res"},{"key":"19504_CR10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"The Cancer Genome Atlas Network","year":"2012","unstructured":"The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330\u20137. https:\/\/doi.org\/10.1038\/nature11252.","journal-title":"Nature"},{"key":"19504_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3390\/cells13080679","volume":"13","author":"J Wang","year":"2024","unstructured":"Wang J, Botvinov J, Bhatt AJ, et al. Somatic mutations in surgically treated colorectal liver metastases: an overview. Cells. 2024;13:679. https:\/\/doi.org\/10.3390\/cells13080679.","journal-title":"Cells"},{"key":"19504_CR12","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.1158\/1078-0432.CCR-19-0863","volume":"25","author":"Y Kawaguchi","year":"2019","unstructured":"Kawaguchi Y, Kopetz S, Newhook TE, et al. Mutation status of RAS, TP53, and SMAD4 is superior to mutation status of RAS alone for predicting prognosis after resection of colorectal liver metastases. Clin Cancer Res. 2019;25:5843\u201351. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-0863.","journal-title":"Clin Cancer Res"},{"key":"19504_CR13","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/bjs.10490","volume":"104","author":"BC Odisio","year":"2017","unstructured":"Odisio BC, Yamashita S, Huang SY, et al. Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status. Br J Surg. 2017;104:760\u20138. https:\/\/doi.org\/10.1002\/bjs.10490.","journal-title":"Br J Surg"},{"key":"19504_CR14","doi-asserted-by":"publisher","first-page":"66117","DOI":"10.18632\/oncotarget.19806","volume":"8","author":"W Shady","year":"2017","unstructured":"Shady W, Petre EN, Vakiani E, et al. Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases. Oncotarget. 2017;8:66117\u201327. https:\/\/doi.org\/10.18632\/oncotarget.19806.","journal-title":"Oncotarget"},{"key":"19504_CR15","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1158\/1078-0432.CCR-18-1726","volume":"25","author":"I Wasserman","year":"2019","unstructured":"Wasserman I, Lee LH, Ogino S, et al. SMAD4 loss in colorectal cancer patients correlates with recurrence, loss of immune infiltrate, and chemoresistance. Clin Cancer Res. 2019;25:1948\u201356. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1726.","journal-title":"Clin Cancer Res"},{"key":"19504_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-024-07769-3","volume":"633","author":"L Nunes","year":"2024","unstructured":"Nunes L, Li F, Wu M, et al. Prognostic genome and transcriptome signatures in colorectal cancers. Nature. 2024;633:137\u201346. https:\/\/doi.org\/10.1038\/s41586-024-07769-3.","journal-title":"Nature"},{"key":"19504_CR17","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1200\/JCO.2009.27.0652","volume":"28","author":"A De La Chapelle","year":"2010","unstructured":"De La Chapelle A, Hampel H. Clinical relevance of microsatellite instability in colorectal cancer. JCO. 2010;28:3380\u20137. https:\/\/doi.org\/10.1200\/JCO.2009.27.0652.","journal-title":"JCO"},{"key":"19504_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.974793","volume":"13","author":"H Hua","year":"2023","unstructured":"Hua H, He W, Chen N, et al. Genomic and transcriptomic analysis of MSI-H colorectal cancer patients with targetable alterations identifies clinical implications for immunotherapy. Front Immunol. 2023;13:974793. https:\/\/doi.org\/10.3389\/fimmu.2022.974793.","journal-title":"Front Immunol"},{"key":"19504_CR19","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1158\/1078-0432.CCR-14-0332","volume":"20","author":"S Venderbosch","year":"2014","unstructured":"Venderbosch S, Nagtegaal ID, Maughan TS, et al. Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies. Clin Cancer Res. 2014;20:5322\u201330. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0332.","journal-title":"Clin Cancer Res"},{"key":"19504_CR20","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00428-018-2359-4","volume":"472","author":"Y Wang","year":"2018","unstructured":"Wang Y, Liu H, Hou Y, et al. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients. Virchows Arch. 2018;472:959\u201368. https:\/\/doi.org\/10.1007\/s00428-018-2359-4.","journal-title":"Virchows Arch"},{"key":"19504_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jmoldx.2017.11.007","volume":"20","author":"L Zhu","year":"2018","unstructured":"Zhu L, Huang Y, Fang X, et al. A novel and reliable method to detect microsatellite instability in colorectal cancer by next-generation sequencing. J Mol Diagn. 2018;20:225\u201331. https:\/\/doi.org\/10.1016\/j.jmoldx.2017.11.007.","journal-title":"J Mol Diagn"},{"key":"19504_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell","year":"1996","unstructured":"Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361\u201387. https:\/\/doi.org\/10.1002\/(SICI)1097-0258(19960229)15:4%3c361::AID-SIM168%3e3.0.CO;2-4.","journal-title":"Stat Med"},{"key":"19504_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1080\/24709360.2021.1926189","volume":"5","author":"N Pantoja-Galicia","year":"2021","unstructured":"Pantoja-Galicia N, Okereke OI, Blacker D, Betensky RA. Concordance measures and time-dependent ROC methods. Biostat Epidemiol. 2021;5:232\u201349. https:\/\/doi.org\/10.1080\/24709360.2021.1926189.","journal-title":"Biostat Epidemiol"},{"key":"19504_CR24","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3390\/cancers14030816","volume":"14","author":"R Rhaiem","year":"2022","unstructured":"Rhaiem R, Rached L, Tashkandi A, Bouch\u00e9 O, Kianmanesh R. Implications of RAS mutations on oncological outcomes of surgical resection and thermal ablation techniques in the treatment of colorectal liver metastases. Cancers. 2022;14:816. https:\/\/doi.org\/10.3390\/cancers14030816.","journal-title":"Cancers"},{"key":"19504_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/annonc\/mdx738","volume":"29","author":"T Yoshino","year":"2018","unstructured":"Yoshino T, Arnold D, Taniguchi H, et al. Pan-asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO\u2013ESMO initiative endorsed by CSCO, KACO, MOS. SSO and TOS Ann Oncol. 2018;29:44\u201370. https:\/\/doi.org\/10.1093\/annonc\/mdx738.","journal-title":"SSO and TOS. Ann Oncol"},{"key":"19504_CR26","doi-asserted-by":"publisher","first-page":"21781","DOI":"10.1038\/s41598-025-05203-w","volume":"15","author":"S Kim","year":"2025","unstructured":"Kim S, Han HJ, Han J, et al. MO-2097 inhibits EMT and angiogenesis in colorectal cancer by targeting RAF\/MEK\/ERK signaling. Sci Rep. 2025;15:21781. https:\/\/doi.org\/10.1038\/s41598-025-05203-w.","journal-title":"Sci Rep"},{"key":"19504_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1101\/gad.352081.124","volume":"39","author":"AD Cox","year":"2025","unstructured":"Cox AD, Der CJ. \u201cUndruggable KRAS\u201d: druggable after all. Genes Dev. 2025;39:132\u201362. https:\/\/doi.org\/10.1101\/gad.352081.124.","journal-title":"Genes Dev"},{"key":"19504_CR28","doi-asserted-by":"publisher","first-page":"2501792","DOI":"10.1002\/advs.202501792","volume":"12","author":"R Wang","year":"2025","unstructured":"Wang R, Li W, Lv Y, et al. Colorectal cancer cells-derived exosomal PIK3CA mutation DNA promotes tumor metastasis by activating fibroblast and affecting tumor metastatic microenvironment. Adv Sci. 2025;12:2501792. https:\/\/doi.org\/10.1002\/advs.202501792.","journal-title":"Adv Sci"},{"key":"19504_CR29","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1158\/1078-0432.CCR-16-0520","volume":"23","author":"T Yamamoto","year":"2017","unstructured":"Yamamoto T, Kawada K, Itatani Y, et al. Loss of SMAD4 Promotes lung metastasis of colorectal cancer by accumulation of CCR1+ tumor-associated neutrophils through CCL15-CCR1 axis. Clin Cancer Res. 2017;23:833\u201344. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0520.","journal-title":"Clin Cancer Res"},{"key":"19504_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41392-021-00501-x","volume":"6","author":"T Shen","year":"2021","unstructured":"Shen T, Liu JL, Wang CY, et al. Targeting erbin in B cells for therapy of lung metastasis of colorectal cancer. Sig Transduct Target Ther. 2021;6:115. https:\/\/doi.org\/10.1038\/s41392-021-00501-x.","journal-title":"Sig Transduct Target Ther"},{"key":"19504_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.961350","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, Xu X, Wu Z, et al. Integrated single-cell RNA-seq analysis identifies immune heterogeneity associated with KRAS\/TP53 mutation status and tumor-sideness in colorectal cancers. Front Immunol. 2022;13:961350. https:\/\/doi.org\/10.3389\/fimmu.2022.961350.","journal-title":"Front Immunol"},{"key":"19504_CR32","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/annonc\/mds614","volume":"24","author":"MA Merok","year":"2013","unstructured":"Merok MA, Ahlquist T, Royrvik EC, et al. Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive norwegian series. Ann Oncol. 2013;24:1274\u201382. https:\/\/doi.org\/10.1093\/annonc\/mds614.","journal-title":"Ann Oncol"},{"key":"19504_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00384-023-04480-z","volume":"38","author":"P Rantanen","year":"2023","unstructured":"Rantanen P, Ker\u00e4nen A, Barot S, et al. The prognostic significance of microsatellite instability in colorectal cancer: a Swedish multi-center study. Int J Colorectal Dis. 2023;38:197. https:\/\/doi.org\/10.1007\/s00384-023-04480-z.","journal-title":"Int J Colorectal Dis"},{"key":"19504_CR34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejca.2022.07.020","volume":"175","author":"J Taieb","year":"2022","unstructured":"Taieb J, Svrcek M, Cohen R, Basile D, Tougeron D, Phelip JM. Deficient mismatch repair\/microsatellite unstable colorectal cancer: diagnosis, prognosis and treatment. Eur J Cancer. 2022;175:136\u201357. https:\/\/doi.org\/10.1016\/j.ejca.2022.07.020.","journal-title":"Eur J Cancer"},{"key":"19504_CR35","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","volume":"36","author":"MJ Overman","year":"2018","unstructured":"Overman MJ, Lonardi S, Wong KYM, et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol. 2018;36:773\u20139. https:\/\/doi.org\/10.1200\/JCO.2017.76.9901.","journal-title":"J Clin Oncol"},{"key":"19504_CR36","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","volume":"383","author":"T Andre","year":"2020","unstructured":"Andre T, Shiu KK, Kim TW, et al. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N Engl J Med. 2020;383:2207\u201318. https:\/\/doi.org\/10.1056\/NEJMoa2017699.","journal-title":"N Engl J Med"},{"key":"19504_CR37","doi-asserted-by":"publisher","first-page":"1073360","DOI":"10.3389\/fendo.2023.1073360","volume":"14","author":"Z Ma","year":"2023","unstructured":"Ma Z, Yang S, Yang Y, Luo J, Zhou Y, Yang H. Development and validation of prediction models for the prognosis of colon cancer with lung metastases: a population-based cohort study. Front Endocrinol. 2023;14:1073360. https:\/\/doi.org\/10.3389\/fendo.2023.1073360.","journal-title":"Front Endocrinol"},{"key":"19504_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/humu.22496","volume":"35","author":"V Kosmidou","year":"2014","unstructured":"Kosmidou V, Oikonomou E, Vlassi M, et al. Tumor heterogeneity revealed by KRAS, BRAF, and PIK3CA pyrosequencing: KRAS and PIK3CA intratumor mutation profile differences and their therapeutic implications. Human Mutat. 2014;35:329\u201340. https:\/\/doi.org\/10.1002\/humu.22496.","journal-title":"Human Mutat."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19504-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19504-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19504-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:52:23Z","timestamp":1780761143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19504-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["19504"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19504-5","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Review Committee of our hospital (Approval No. IEC 2024 1 074 The requirement for informed consent was waived due to the retrospective nature of the study. All procedures were conducted in accordance with the ethical standards of the responsible committee on hum an experimentation and the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}